Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border.

Weber C, Krug O, Kamber M, Thevis M.

Subst Use Misuse. 2017 May 12;52(6):742-753. doi: 10.1080/10826084.2016.1263665. Epub 2017 Feb 3.

PMID:
28156209
2.

Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination.

Helmlin HJ, Mürner A, Steiner S, Kamber M, Weber C, Geyer H, Guddat S, Schänzer W, Thevis M.

Forensic Sci Int. 2016 Oct;267:166-172. doi: 10.1016/j.forsciint.2016.08.029. Epub 2016 Aug 28.

PMID:
27611956
3.

Seizures of doping substances at the Swiss Border--a descriptive investigation.

Weber C, Kamber M, Lentillon-Kaestner V, Krug O, Thevis M.

Forensic Sci Int. 2015 Dec;257:359-368. doi: 10.1016/j.forsciint.2015.10.001. Epub 2015 Oct 22.

PMID:
26517824
4.

Angiotensin II inhibitor facilitates epidermal wound regeneration in diabetic mice.

Kamber M, Papalazarou V, Rouni G, Papageorgopoulou E, Papalois A, Kostourou V.

Front Physiol. 2015 Jun 9;6:170. doi: 10.3389/fphys.2015.00170. eCollection 2015.

5.

Doping mit Anabolika - auch ein Thema für den Hausarzt!

Bieri A, Kamber M, Sterchi M, Mullis PE.

Ther Umsch. 2014 Apr;71(4):245-52. doi: 10.1024/0040-5930/a000508. German.

PMID:
24670606
6.
7.

Development of the role of national anti-doping organisations in the fight against doping: from past to future.

Kamber M.

Forensic Sci Int. 2011 Dec 10;213(1-3):3-9. doi: 10.1016/j.forsciint.2011.07.026. Epub 2011 Aug 11.

PMID:
21835566
8.

Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.

Thevis M, Geyer H, Kamber M, Schänzer W.

Drug Test Anal. 2009 Aug;1(8):387-92. doi: 10.1002/dta.91.

PMID:
20355219
9.

Temporal indication of cannabis use by means of THC glucuronide determination.

Mareck U, Haenelt N, Geyer H, Guddat S, Kamber M, Brenneisen R, Thevis M, Schänzer W.

Drug Test Anal. 2009 Nov;1(11-12):505-10. doi: 10.1002/dta.106.

PMID:
20355165
10.

Quantification of urinary AICAR concentrations as a matter of doping controls.

Thomas A, Beuck S, Eickhoff JC, Guddat S, Krug O, Kamber M, Schänzer W, Thevis M.

Anal Bioanal Chem. 2010 Apr;396(8):2899-908. doi: 10.1007/s00216-010-3560-8. Epub 2010 Mar 12.

PMID:
20225061
11.

The worldwide fight against doping: from the beginning to the World Anti-Doping Agency.

Kamber M, Mullis PE.

Endocrinol Metab Clin North Am. 2010 Mar;39(1):1-9, vii. doi: 10.1016/j.ecl.2009.10.009.

PMID:
20122445
12.
13.

Interspecies crosses: aspects of animal protection.

Kamber MG, Steiger A, Aus der Au C, Baertschi B, Bondolfi A, Brenner A, Bürki K, Durrer H, Guztwiller A, Heiniger B, Hummler E, Jakob S, Kuehnle K, Lanzrein B, Ledermann B, Leuthold W, Matter B, Reiderer B, Rippe KP, Stadler B, Tinner M, Wannier T; Ethics Committee for Animal Studies.

ALTEX. 2009;26(3):227-31. No abstract available.

14.

Unusual mass spectrometric dissociation pathway of protonated isoquinoline-3-carboxamides due to multiple reversible water adduct formation in the gas phase.

Beuck S, Schwabe T, Grimme S, Schlörer N, Kamber M, Schänzer W, Thevis M.

J Am Soc Mass Spectrom. 2009 Nov;20(11):2034-48. doi: 10.1016/j.jasms.2009.07.016. Epub 2009 Aug 7.

15.

Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry.

Thomas A, Kohler M, Schänzer W, Kamber M, Delahaut P, Thevis M.

Rapid Commun Mass Spectrom. 2009 Sep;23(17):2669-74. doi: 10.1002/rcm.4176.

PMID:
19630025
16.

Comparison of the Salmonella/microsome microsuspension assay with the new microplate fluctuation protocol for testing the mutagenicity of environmental samples.

Umbuzeiro Gde A, Rech CM, Correia S, Bergamasco AM, Cardenette GH, Flückiger-Isler S, Kamber M.

Environ Mol Mutagen. 2010 Jan;51(1):31-8. doi: 10.1002/em.20504.

PMID:
19484728
17.

Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity.

Kamber M, Flückiger-Isler S, Engelhardt G, Jaeckh R, Zeiger E.

Mutagenesis. 2009 Jul;24(4):359-66. doi: 10.1093/mutage/gep017. Epub 2009 May 15.

PMID:
19447896
18.

Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.

Thomas A, Geyer H, Kamber M, Schänzer W, Thevis M.

J Mass Spectrom. 2008 Jul;43(7):908-15. doi: 10.1002/jms.1453.

PMID:
18563864
19.

The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration.

Diel P, Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Schleipen B, Thevis M, Vollmer G, Zierau O.

Toxicol Lett. 2008 Apr 1;177(3):198-204. doi: 10.1016/j.toxlet.2008.01.014. Epub 2008 Feb 2.

PMID:
18325697
20.

Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS.

Thevis M, Kohler M, Thomas A, Maurer J, Schlörer N, Kamber M, Schänzer W.

Anal Bioanal Chem. 2008 May;391(1):251-61. doi: 10.1007/s00216-008-1882-6. Epub 2008 Feb 13.

PMID:
18270691
21.

Mass spectrometry of hydantoin-derived selective androgen receptor modulators.

Thevis M, Kohler M, Schlörer N, Kamber M, Kühn A, Linscheid MW, Schänzer W.

J Mass Spectrom. 2008 May;43(5):639-50.

PMID:
18095383
22.

Aryl-propionamide-derived selective androgen receptor modulators: liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes.

Kuuranne T, Leinonen A, Schänzer W, Kamber M, Kostiainen R, Thevis M.

Drug Metab Dispos. 2008 Mar;36(3):571-81. Epub 2007 Dec 17.

PMID:
18086831
23.

The public perception of doping in sport in Switzerland, 1995-2004.

Stamm H, Lamprecht M, Kamber M, Marti B, Mahler N.

J Sports Sci. 2008 Feb 1;26(3):235-42.

PMID:
18074297
24.

Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.

Thevis M, Kohler M, Maurer J, Schlörer N, Kamber M, Schänzer W.

Rapid Commun Mass Spectrom. 2007;21(21):3477-86.

PMID:
17985352
25.

Possible origins of undetectable EPO in urine samples.

Lamon S, Robinson N, Sottas PE, Henry H, Kamber M, Mangin P, Saugy M.

Clin Chim Acta. 2007 Oct;385(1-2):61-6. Epub 2007 Jul 10.

PMID:
17692836
26.

Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping.

Diel P, Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Thevis M, Vollmer G, Zierau O.

Toxicol Lett. 2007 Feb 28;169(1):64-71. Epub 2006 Dec 27.

PMID:
17254722
27.

[Doping in adolescence].

Kamber M, Mullis PE.

Ther Umsch. 2007 Feb;64(2):83-9. Review. German.

PMID:
17245674
28.

Determination of Synacthen in human plasma using immunoaffinity purification and liquid chromatography/tandem mass spectrometry.

Thevis M, Bredehöft M, Geyer H, Kamber M, Delahaut P, Schänzer W.

Rapid Commun Mass Spectrom. 2006;20(23):3551-6.

PMID:
17099925
29.

Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio.

Sottas PE, Baume N, Saudan C, Schweizer C, Kamber M, Saugy M.

Biostatistics. 2007 Apr;8(2):285-96. Epub 2006 Jun 19.

PMID:
16785250
30.

Dynamic targeting image-guided radiotherapy.

Huntzinger C, Munro P, Johnson S, Miettinen M, Zankowski C, Ahlstrom G, Glettig R, Filliberti R, Kaissl W, Kamber M, Amstutz M, Bouchet L, Klebanov D, Mostafavi H, Stark R.

Med Dosim. 2006 Summer;31(2):113-25. Review.

PMID:
16690452
31.

17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.

Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Thevis M, Vollmer G, Zierau O, Diel P.

Toxicol Lett. 2006 Aug 20;165(2):149-55. Epub 2006 Apr 18.

PMID:
16621347
32.
33.

Research of stimulants and anabolic steroids in dietary supplements.

Baume N, Mahler N, Kamber M, Mangin P, Saugy M.

Scand J Med Sci Sports. 2006 Feb;16(1):41-8.

PMID:
16430680
34.

Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver.

Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Thevis M, Vollmer G, Zierau O, Diel P.

Toxicol Lett. 2006 Jun 20;164(1):16-23. Epub 2005 Dec 13.

PMID:
16356667
35.

Longitudinal profiling of urinary steroids by gas chromatography/combustion/isotope ratio mass spectrometry: diet change may result in carbon isotopic variations.

Saudan C, Kamber M, Barbati G, Robinson N, Desmarchelier A, Mangin P, Saugy M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):324-7. Epub 2005 Dec 9.

PMID:
16338181
36.

Doping test reveals high concentrations of salbutamol in a Swiss track and field athlete.

Schweizer C, Saugy M, Kamber M.

Clin J Sport Med. 2004 Sep;14(5):312-5.

PMID:
15377972
37.
38.

Genetic analysis and functional characterization of the Streptococcus pneumoniae vic operon.

Wagner C, Saizieu Ad Ad, Schönfeld HJ, Kamber M, Lange R, Thompson CJ, Page MG.

Infect Immun. 2002 Nov;70(11):6121-8.

39.

Nutritional supplements as a source for positive doping cases?

Kamber M, Baume N, Saugy M, Rivier L.

Int J Sport Nutr Exerc Metab. 2001 Jun;11(2):258-63.

PMID:
11402257
40.

[Fight against doping--national and international developments after Tour de France 1998].

Kamber M.

Ther Umsch. 2001 Apr;58(4):220-5. Review. German.

PMID:
11344953
42.

Microarray-based identification of a novel Streptococcus pneumoniae regulon controlled by an autoinduced peptide.

de Saizieu A, Gardès C, Flint N, Wagner C, Kamber M, Mitchell TJ, Keck W, Amrein KE, Lange R.

J Bacteriol. 2000 Sep;182(17):4696-703.

43.

Creatine supplementation--part II: in vivo magnetic resonance spectroscopy.

Kreis R, Kamber M, Koster M, Felblinger J, Slotboom J, Hoppeler H, Boesch C.

Med Sci Sports Exerc. 1999 Dec;31(12):1770-7.

PMID:
10613427
44.

Creatine supplementation--part I: performance, clinical chemistry, and muscle volume.

Kamber M, Koster M, Kreis R, Walker G, Boesch C, Hoppeler H.

Med Sci Sports Exerc. 1999 Dec;31(12):1763-9.

PMID:
10613426
45.

Domain organization and molecular characterization of 13 two-component systems identified by genome sequencing of Streptococcus pneumoniae.

Lange R, Wagner C, de Saizieu A, Flint N, Molnos J, Stieger M, Caspers P, Kamber M, Keck W, Amrein KE.

Gene. 1999 Sep 3;237(1):223-34.

PMID:
10524254
46.

Integrational plasmids for the tetracycline-regulated expression of genes in Streptococcus pneumoniae.

Stieger M, Wohlgensinger B, Kamber M, Lutz R, Keck W.

Gene. 1999 Jan 21;226(2):243-51.

PMID:
9931496
47.

Discordant public perception of doping in elite versus recreational sport in Switzerland.

Nocelli L, Kamber M, François Y, Gmel G, Marti B.

Clin J Sport Med. 1998 Jul;8(3):195-200.

PMID:
9762478
48.

Peak assignment in localized 1H MR spectra of human muscle based on oral creatine supplementation.

Kreis R, Koster M, Kamber M, Hoppeler H, Boesch C.

Magn Reson Med. 1997 Feb;37(2):159-63.

PMID:
9001137
49.

Modulation of epidermal differentiation, tissue inflammation, and T-lymphocyte infilitration in psoriatic plaques by topical calcitriol.

Lu I, Gilleaudeau P, McLane JA, Heftler N, Kamber M, Gottlieb S, Krueger JG, Gottlieb AB.

J Cutan Pathol. 1996 Oct;23(5):419-30.

PMID:
8915850
50.

Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor.

Apfel CM, Kamber M, Klaus M, Mohr P, Keidel S, LeMotte PK.

J Biol Chem. 1995 Dec 22;270(51):30765-72.

Supplemental Content

Loading ...
Support Center